Skip to main content
. Author manuscript; available in PMC: 2015 Nov 14.
Published in final edited form as: Clin Ther. 2014 Nov 14;36(11):1518–1530. doi: 10.1016/j.clinthera.2014.10.003

Table 1.

Sociodemographic and clinical characteristics of the cohort (N=242) stratified according to depressive symptoms (Baseline CES-D > 10). All are n (%) unless otherwise notated.

Demographic characteristics Total N=242 CESD <10 N=153 CES-D ≥ 11 N=89 p
Age, mean (SD) 63.2 (±11.2) 64.2 (±10.9) 61.5 (±11.5) 0.07
Women 73 (30.2%) 40 (26.1) 33 (37.1%) 0.07
Race
    Caucasian 196 (81.0%) 130 (85.0) 66 (74.2%) <0.02
    Black 26 (10.7%) 12 (7.8) 14 (15.7%)
    Asian 10 (4.1%) 8 (5.2) 2 (2.3%)
    Multiracial 10 (4.1%) 3 (2.0) 7 (7.9)
Hispanic ethnicity 31 (12.8%) 16 (10.5) 15 (16.9%) 0.15
Married/Partnered 170 (70.2%) 112(73.7) 55 (63.2%) 0.09
Widowed 15 (6.2%) 9 (5.9) 6 (6.9%)
Separated/Divorced 31 (12.8%) 17 (11.2) 14 (16.1%)
Never married 26 (10.7%) 14 (9.2) 12 (13.8%)
Education
    < High School 18 (7.4%) 10 (6.5) 8 (9.0%) 0.05
    Completed High School 91 (37.6%) 51 (33.3) 40 (44.9%)
    College or > 133 (54.9%) 92 (60.1) 41 (46.1%)
Clinical characteristics
Body Mass Index*
    Normal, < 25 59 (24.5%) 39 (25.5) 20 (22.7%) 0.45
    Overweight, ≥ 25 to < 30 95 (39.4%%) 62 (40.5) 33 (37.5%)
    Obese, ≥ 30 87 (36.1%) 52 (34.0) 35 (39.8%)
Seattle Angina Questionnaire,32 mean score (SD)
    Physical limitation (n=241) 70.7 (±18.0) 74.6 (±14.3) 64.1 (±21.6) <0.0001
    Angina stability (n=237) 37.9 (±29.1) 42.0 (±27.4) 30.5 (±30.8) 0.003
    Angina frequency (n=241) 70.8 (±23.1) 75.6 (±21.6) 62.1 (±24.2) <0.0001
    Treatment satisfaction (n=241) 90.3 (±8.9) 89.0 (±10.2) 89.0 (±8.6) 0.13
    Disease perception (n=241) 50.1 (±25.3) 57.9 (±24.7) 36.3 (±20.3) <0.0001
MI 70 (28.9%) 44 (28.8) 26 (29.2%) 0.94
CHF 12 (5.0%) 6 (3.9) 6 (6.7%) 0.37
Asthma/bronchitis 41 (16.9%) 20 (13.1) 21 (23.6%) 0.03
Previous Angioplasty 91 (37.6%) 57 (37.3) 34 (38.2%) 0.88
Diabetes 61 (25.2%) 34 (22.2) 27 (30.3%) 0.16
Smoking history 166 (68.6%) 101(66.0) 65 (73.0%) 0.26
Rheumatic disease 16 (6.6%) 8 (5.2) 8 (9.0%) 0.26
Peripheral vascular disease 32 (13.2%) 12 (7.8) 20 (22.5%) 0.001
Stroke 16 (6.6%) 8 (5.2) 8 (9.0%) 0.26
Cancer 34 (14.0%) 22(14.4) 12(13.5%) 0.85
Liver disease 4 (1.7%) 3 (2.0) 1 (1.1%) 1.0
Charlson Index6
    0-1 137 (56.6%) 92 (60.1) 45 (50.6%) 0.16
    2-3 49 (20.3%) 29(18.9) 20 (22.5%)
    ≥ 4 56 (23.1%) 32 (20.9) 24 (26.9%)
*

calculated as weight in kilograms divided by height in meters squared